Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma.

Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Abstract Text:

    r o pritchard-jonesR O Pritchard-Jones,d b a dunnD B A Dunn,y qiuY Qiu,a h r vareyA H R Varey,a orlandoA Orlando,h rigbyH Rigby,s j harperS J Harper,d o batesD O Bates,

    Malignant melanoma is the most lethal of the skin cancers and the UK incidence is rising faster than that of any other cancer. Angiogenesis - the growth of new vessels from preexisting vasculature - is an absolute requirement for tumour survival and progression beyond a few hundred microns in diameter. We previously described a class of anti-angiogenic isoforms of VEGF, VEGF(xxx)b, that inhibit tumour growth in animal models, and are downregulated in some cancers, but have not been investigated in melanoma. To determine whether VEGF(xxx)b expression was altered in melanoma, PCR and immunohistochemistry of archived human tumour samples were used. In normal epidermis and in a proportion of melanoma samples, VEGF(xxx)b staining was seen. Some melanomas had much weaker staining. Subsequent examination revealed that expression was significantly reduced in primary melanoma samples (both horizontal and vertical growth phases) from patients who subsequently developed tumour metastasis compared with those who did not (analysis of variance (ANOVA) P<0.001 metastatic vs nonmetastatic), irrespective of tumour thickness, while the surrounding epidermis showed no difference in expression. Staining for total VEGF expression showed staining in metastatic and nonmetastatic melanomas, and normal epidermis. An absence of VEGF(xxx)b expression appears to predict metastatic spread in patients with primary melanoma. These results suggest that there is a switch in splicing as part of the metastatic process, from anti-angiogenic to pro-angiogenic VEGF isoforms. This may form part of a wider metastatic splicing phenotype.

    Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Publishing Authors By Initials

    ro pritchard-jonesRO Pritchard-Jones,db dunnDB Dunn,y qiuY Qiu,ah vareyAH Varey,a orlandoA Orlando,h rigbyH Rigby,sj harperSJ Harper,do batesDO Bates,

    For similar peptides: intercellular signaling peptides and proteins: angiogenic proteins: vascular endothelial growth factors: vascular endothelial growth factor a research abstracts see: peptides: intercellular signaling peptides and proteins: angiogenic proteins: vascular endothelial growth factors: vascular endothelial growth factor a research

    PUBMED ID PMID:

    MEDLINE DATE:

    Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: British journal of cancer

    VOLUME: 97

    Page Numbers: 223-30

    Journal Abbreviation: Br. J. Cancer

    ISSN: 0007-0920

    DAY: 26

    MONTH: 06

    YEAR: 2007

    Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370635

    Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Keywords Mesh Terms:

    KEYWORDS: Vascular Endothelial Growth Factor A

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Information

    Substance Name: Vascular Endothelial Growth Factor A

    Registry Number: 0

    Grant and Affiliation Information for Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma.

    AFFILIATION: Microvascular Research Laboratories, Department of Physiology, Preclinical Veterinary School, University of Bristol, Bristol, UK.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Br J Cancer

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News